MASUI
REGN icon

MIRAE ASSET SECURITIES (USA) INC.’s Regeneron Pharmaceuticals REGN Stock Holding History

MIRAE ASSET SECURITIES (USA) INC.’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5,000
Closed -$2.63M – 223
2025
Q2 		$2.63M Buy
5,000
+200
+4% +$112K 0.08% 148
2025
Q1 		$3.04M Hold
4,800
– – 0.08% 136
2024
Q4 		$3.42M Buy
4,800
+1,000
+26% +$839K 0.1% 97
2024
Q3 		$3.99M Buy
3,800
+1,600
+73% +$1.78M 0.16% 96
2024
Q2 		$2.31M Buy
+2,200
New +$2.13M 0.11% 125

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MIRAE ASSET SECURITIES (USA) INC.'s REGN Position: Q3 2025 in Review

MIRAE ASSET SECURITIES (USA) INC. sold out of Regeneron Pharmaceuticals (REGN) in Q3 2025, closing a stake of 5,013 shares — an estimated $2.63M sold.

MIRAE ASSET SECURITIES (USA) INC. first reported a position in REGN in Q2 2024 and held it in 5 quarters. The position peaked at $3.99M in Q3 2024. 1,245 funds tracked by Wall St. Rank hold REGN as of Q3 2025.

  • MIRAE ASSET SECURITIES (USA) INC. reported no remaining Regeneron Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • MIRAE ASSET SECURITIES (USA) INC. sold 5,013 Regeneron Pharmaceuticals shares in Q3 2025, an estimated $2.63M.
  • MIRAE ASSET SECURITIES (USA) INC. first reported a position in Regeneron Pharmaceuticals in Q2 2024 and held it in 5 quarters.
  • MIRAE ASSET SECURITIES (USA) INC.'s Regeneron Pharmaceuticals position peaked at $3.99M in Q3 2024.
  • 1,245 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2025.

Based on MIRAE ASSET SECURITIES (USA) INC.'s 13F filing for Q3 2025, filed 24 Oct 2025.